ENROLL-HD – Neuroprogressive and Dementia Network

Huntington’s Disease Research

Enroll-HD is a study designed to speed up the development of treatments for Huntington’s disease by gathering consistent clinical data and biological samples to better understand the disease’s progression. This study will create a comprehensive and valuable database accessible to researchers around the world. Additionally, Enroll-HD will help identify volunteers who are suitable for upcoming treatment trials. More information on this study can be found on the Enroll-HD website.

This study is open to recruitment

To find out more about this research study, please contact:
loth.sdcrn@nhs.scot
0131 537 3804

Key Staff

NDN Principal Investigator: Dr Peter Foley

This study is looking at patients with Huntington’s disease.

CONTACT INFORMATION

Neuroprogressive & Dementia Research Network Office

Old Pharmacy Building
Western General Hospital
Edinburgh
EH4 2XU

Email: loth.sdcrn@nhs.scot

Telephone: 0131 537 3804

ABOUT US

The NRS Neuroprogressive Disease and Dementia Network team in NHS Lothian conduct commercial and investigator led studies for: Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, Motor Neurone Disease, dementia with Lewy bodies, Progressive Supranuclear Palsy and Multiple System Atrophy.